Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Remote Patient Monitoring Market by Condition (Congestive Heart Failure (CHF), Diabetes, Chronic Obstructive Pulmonary Disease (COPD), Blood Pressure, Mental Health, Others), by Component (Devices, Software): Global Opportunity Analysis and Industry Forecast, 2021-2031

A01400

Pages: 220

Charts: 57

Tables: 120

Remote Patient Monitoring Market Research, 2031

The global remote patient monitoring market was valued at $1.9 billion in 2021, and is projected to reach $8.5 billion by 2031, growing at a CAGR of 16.3% from 2022 to 2031.

Remote patient monitoring collects medical and other types of health data like clinical data, patient registry and patient current health status is transmitted to a healthcare provider using digital technologies. The information can be gathered at patient's home, saving money on care and hospitalization. Increase in number of geriatric population and rise in disposable income drive the growth of the remote patient monitoring market share. In recent years, there has been an increase in demand to improve healthcare infrastructure, surge in cost benefits of telehealth, and rise in remote patient monitoring technologies, owing to the rapidly growing global population and surge in occurrence of chronic diseases.

Get more information on this report : Request Sample Pages

The growth of remote patient monitoring market size is driven by increase in the prevalence of lifestyle disorder, increase in usage of remote patient monitoring devices, and an increase in the geriatric population. Remote patient monitoring devices are becoming more popular across the globe since they are simple to use and can be utilized by people of all ages. Furthermore, geriatric population is more prone to chronic disorders, hence, remote patient devices are used by them. According to the World Population Ageing 2020 study, in 2020, there were $703 million individuals aged 65 and above across the globe. In 2050, this population is expected to increase to $1.5 billion. Globally, the proportion of people aged 65 and above surged from 6% in 1990 to 9% in 2019, with a projected growth rate of 16% in 2050. Government rules, reimbursement concerns, lack of awareness, and exorbitant expenses, on the other hand, hinder the market expansion. On the contrary, technological improvements are projected to provide profitable prospects for market players in the future. Remote monitoring systems, mobile cardiac telemetry devices, mobile personal digital assistant (PDA) systems, ambulatory wireless EEG recorders, and ambulatory event monitors are important elements supporting the  remote patient monitoring market growth. Furthermore, these gadgets are small and portable, allowing patients to use them every time without any discomfort. In addition, these technologies allow for continuous monitoring of the patient's condition. Rise in demand for home-based monitoring equipment drives the growth of the market during remote patient monitoring market forecast. According to the Center for Medicare and Medicaid Services 2021, every year, remote monitors assist several high-risk patients from the preventing to be  readmitted. to the hospital. Remote monitoring clients report a 76% decrease in readmission rates, an average of 89 % patient satisfaction, and a total medical cost savings of over $370 million.

The World Health Organization (WHO) on January 30, 2021 declared COVID-19 as a pandemic and general wellbeing crisis of international concern. COVID-19 has impacted around 210 countries across the globe ,owing to the COVID-19 pandemic. State-run administrations across the globe declared inescapable lockdowns as well as social distancing measures to forestall breakdown of the healthcare structure. States have additionally given constraints and preventions on undertakings and elective surgeries. These obstructions continue to influence the growth of different industries and the enhanced response toward these regulations affects the industry. The distribution, production, and store network have been impacted, due to lockdowns across the globe.

Similarly, the remote patient monitoring market had a positive impact during the pandemic, owing to social distancing norms and least availability of hospital beds prompted for maximum adaptation of home-based patient care system. Hence, overall, the pandemic had a positive impact on remote monitoring market.

The remote patient monitoring market is segmented into Condition and Component.

The emote patient monitoring market size is segmented on the basis of condition, component, and region. By condition, tit is classified into congestive heart failure, diabetes, chronic obstructive pulmonary disease, blood pressure, mental health and others. By component it is segregated into devices and software.

Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

[CONDITIONGRAPH]

Segment Review

By Condition Type

By condition type, the congestive heart failure segment dominated the market in 2021 with a revenue of $916.75 million. Growth of the segment is attributed to rising burden of chronic diseases such as heart diseases due to lifestyle changes and the rising geriatric population.

[COMPONENTGRAPH]

By Component Type

By component type, the device segment dominated the market in 2021 with a revenue of $1,453.63 million. The growth of the segment can be attributed to surge in incidences of chronic diseases, such as diabetes and COPD and the growing demand for home-based monitoring devices are responsible for the high growth rate.

[REGIONGRAPH]

By Region

Region wise, in remote patient monitoring industry, North America dominated the global market in 2021 with a revenue of $746.40 million. The major factors driving the remote patient monitoring market size growth include the growing burden of chronic diseases, increasing geriatric population, demand for wireless and portable systems, and the presence of a sophisticated reimbursement structure.

Major key players that operate in the global remote patient monitoring market are Abott Laboratories, Biotronik SE Co. KG, Boston Scientific Inc., Datos Health, General Electric, Honey Well International, Johnson & Johnson, Koninklijike Philips N.V., Medtronic, and Nihon Kohden.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the remote patient monitoring market analysis from 2021 to 2031 to identify the prevailing remote patient monitoring market opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the remote patient monitoring market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global remote patient monitoring market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

  • By Condition
    • Congestive Heart Failure (CHF)
    • Diabetes
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Blood Pressure
    • Mental Health
    • Others
  • By Component
    • Devices
    • Software
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K.
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • Australia
      • India
      • South Korea
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • Saudi Arabia
      • South Africa
      • Rest of LAMEA


Key Market Players

  • Aerotel Medical Systems (1988) Ltd.
  • Biotronik SE & Co. KG
  • General Electric Company
  • Nihon Kohden Corporation
  • Boston Scientific Corporation
  • Omron Corporation
  • Medtronic Plc
  • Johnson and Johnson
  • Masimo Corporation
  • Abbott Laboratories
  • CHAPTER 1:INTRODUCTION

    • 1.1.Report description

    • 1.2.Key market segments

    • 1.3.Key benefits to the stakeholders

    • 1.4.Research Methodology

      • 1.4.1.Secondary research

      • 1.4.2.Primary research

      • 1.4.3.Analyst tools and models

  • CHAPTER 2:EXECUTIVE SUMMARY

    • 2.1.Key findings of the study

    • 2.2.CXO Perspective

  • CHAPTER 3:MARKET OVERVIEW

    • 3.1.Market definition and scope

    • 3.2.Key findings

      • 3.2.1.Top investment pockets

    • 3.3.Porter’s five forces analysis

    • 3.4.Top player positioning

    • 3.5.Market dynamics

      • 3.5.1.Drivers

      • 3.5.2.Restraints

      • 3.5.3.Opportunities

    • 3.6.COVID-19 Impact Analysis on the market

  • CHAPTER 4: REMOTE PATIENT MONITORING MARKET, BY CONDITION

    • 4.1 Overview

      • 4.1.1 Market size and forecast

    • 4.2 Congestive Heart Failure (CHF)

      • 4.2.1 Key market trends, growth factors and opportunities

      • 4.2.2 Market size and forecast, by region

      • 4.2.3 Market analysis by country

    • 4.3 Diabetes

      • 4.3.1 Key market trends, growth factors and opportunities

      • 4.3.2 Market size and forecast, by region

      • 4.3.3 Market analysis by country

    • 4.4 Chronic Obstructive Pulmonary Disease (COPD)

      • 4.4.1 Key market trends, growth factors and opportunities

      • 4.4.2 Market size and forecast, by region

      • 4.4.3 Market analysis by country

    • 4.5 Blood Pressure

      • 4.5.1 Key market trends, growth factors and opportunities

      • 4.5.2 Market size and forecast, by region

      • 4.5.3 Market analysis by country

    • 4.6 Mental Health

      • 4.6.1 Key market trends, growth factors and opportunities

      • 4.6.2 Market size and forecast, by region

      • 4.6.3 Market analysis by country

    • 4.7 Others

      • 4.7.1 Key market trends, growth factors and opportunities

      • 4.7.2 Market size and forecast, by region

      • 4.7.3 Market analysis by country

  • CHAPTER 5: REMOTE PATIENT MONITORING MARKET, BY COMPONENT

    • 5.1 Overview

      • 5.1.1 Market size and forecast

    • 5.2 Devices

      • 5.2.1 Key market trends, growth factors and opportunities

      • 5.2.2 Market size and forecast, by region

      • 5.2.3 Market analysis by country

    • 5.3 Software

      • 5.3.1 Key market trends, growth factors and opportunities

      • 5.3.2 Market size and forecast, by region

      • 5.3.3 Market analysis by country

  • CHAPTER 6: REMOTE PATIENT MONITORING MARKET, BY REGION

    • 6.1 Overview

      • 6.1.1 Market size and forecast

    • 6.2 North America

      • 6.2.1 Key trends and opportunities

      • 6.2.2 North America Market size and forecast, by Condition

      • 6.2.3 North America Market size and forecast, by Component

      • 6.2.4 North America Market size and forecast, by country

        • 6.2.4.1 U.S.
          • 6.2.4.1.1 Market size and forecast, by Condition
          • 6.2.4.1.2 Market size and forecast, by Component
        • 6.2.4.2 Canada
          • 6.2.4.2.1 Market size and forecast, by Condition
          • 6.2.4.2.2 Market size and forecast, by Component
        • 6.2.4.3 Mexico
          • 6.2.4.3.1 Market size and forecast, by Condition
          • 6.2.4.3.2 Market size and forecast, by Component
    • 6.3 Europe

      • 6.3.1 Key trends and opportunities

      • 6.3.2 Europe Market size and forecast, by Condition

      • 6.3.3 Europe Market size and forecast, by Component

      • 6.3.4 Europe Market size and forecast, by country

        • 6.3.4.1 Germany
          • 6.3.4.1.1 Market size and forecast, by Condition
          • 6.3.4.1.2 Market size and forecast, by Component
        • 6.3.4.2 France
          • 6.3.4.2.1 Market size and forecast, by Condition
          • 6.3.4.2.2 Market size and forecast, by Component
        • 6.3.4.3 U.K.
          • 6.3.4.3.1 Market size and forecast, by Condition
          • 6.3.4.3.2 Market size and forecast, by Component
        • 6.3.4.4 Italy
          • 6.3.4.4.1 Market size and forecast, by Condition
          • 6.3.4.4.2 Market size and forecast, by Component
        • 6.3.4.5 Spain
          • 6.3.4.5.1 Market size and forecast, by Condition
          • 6.3.4.5.2 Market size and forecast, by Component
        • 6.3.4.6 Rest of Europe
          • 6.3.4.6.1 Market size and forecast, by Condition
          • 6.3.4.6.2 Market size and forecast, by Component
    • 6.4 Asia-Pacific

      • 6.4.1 Key trends and opportunities

      • 6.4.2 Asia-Pacific Market size and forecast, by Condition

      • 6.4.3 Asia-Pacific Market size and forecast, by Component

      • 6.4.4 Asia-Pacific Market size and forecast, by country

        • 6.4.4.1 Japan
          • 6.4.4.1.1 Market size and forecast, by Condition
          • 6.4.4.1.2 Market size and forecast, by Component
        • 6.4.4.2 China
          • 6.4.4.2.1 Market size and forecast, by Condition
          • 6.4.4.2.2 Market size and forecast, by Component
        • 6.4.4.3 Australia
          • 6.4.4.3.1 Market size and forecast, by Condition
          • 6.4.4.3.2 Market size and forecast, by Component
        • 6.4.4.4 India
          • 6.4.4.4.1 Market size and forecast, by Condition
          • 6.4.4.4.2 Market size and forecast, by Component
        • 6.4.4.5 South Korea
          • 6.4.4.5.1 Market size and forecast, by Condition
          • 6.4.4.5.2 Market size and forecast, by Component
        • 6.4.4.6 Rest of Asia-Pacific
          • 6.4.4.6.1 Market size and forecast, by Condition
          • 6.4.4.6.2 Market size and forecast, by Component
    • 6.5 LAMEA

      • 6.5.1 Key trends and opportunities

      • 6.5.2 LAMEA Market size and forecast, by Condition

      • 6.5.3 LAMEA Market size and forecast, by Component

      • 6.5.4 LAMEA Market size and forecast, by country

        • 6.5.4.1 Brazil
          • 6.5.4.1.1 Market size and forecast, by Condition
          • 6.5.4.1.2 Market size and forecast, by Component
        • 6.5.4.2 Saudi Arabia
          • 6.5.4.2.1 Market size and forecast, by Condition
          • 6.5.4.2.2 Market size and forecast, by Component
        • 6.5.4.3 South Africa
          • 6.5.4.3.1 Market size and forecast, by Condition
          • 6.5.4.3.2 Market size and forecast, by Component
        • 6.5.4.4 Rest of LAMEA
          • 6.5.4.4.1 Market size and forecast, by Condition
          • 6.5.4.4.2 Market size and forecast, by Component
  • CHAPTER 7: COMPANY LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top winning strategies

    • 7.3. Product Mapping of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Key developments

  • CHAPTER 8: COMPANY PROFILES

    • 8.1 Aerotel Medical Systems (1988) Ltd.

      • 8.1.1 Company overview

      • 8.1.2 Company snapshot

      • 8.1.3 Operating business segments

      • 8.1.4 Product portfolio

      • 8.1.5 Business performance

      • 8.1.6 Key strategic moves and developments

    • 8.2 Biotronik SE & Co. KG

      • 8.2.1 Company overview

      • 8.2.2 Company snapshot

      • 8.2.3 Operating business segments

      • 8.2.4 Product portfolio

      • 8.2.5 Business performance

      • 8.2.6 Key strategic moves and developments

    • 8.3 Boston Scientific Corporation

      • 8.3.1 Company overview

      • 8.3.2 Company snapshot

      • 8.3.3 Operating business segments

      • 8.3.4 Product portfolio

      • 8.3.5 Business performance

      • 8.3.6 Key strategic moves and developments

    • 8.4 General Electric Company

      • 8.4.1 Company overview

      • 8.4.2 Company snapshot

      • 8.4.3 Operating business segments

      • 8.4.4 Product portfolio

      • 8.4.5 Business performance

      • 8.4.6 Key strategic moves and developments

    • 8.5 Nihon Kohden Corporation

      • 8.5.1 Company overview

      • 8.5.2 Company snapshot

      • 8.5.3 Operating business segments

      • 8.5.4 Product portfolio

      • 8.5.5 Business performance

      • 8.5.6 Key strategic moves and developments

    • 8.6 Medtronic Plc

      • 8.6.1 Company overview

      • 8.6.2 Company snapshot

      • 8.6.3 Operating business segments

      • 8.6.4 Product portfolio

      • 8.6.5 Business performance

      • 8.6.6 Key strategic moves and developments

    • 8.7 Masimo Corporation

      • 8.7.1 Company overview

      • 8.7.2 Company snapshot

      • 8.7.3 Operating business segments

      • 8.7.4 Product portfolio

      • 8.7.5 Business performance

      • 8.7.6 Key strategic moves and developments

    • 8.8 Abbott Laboratories

      • 8.8.1 Company overview

      • 8.8.2 Company snapshot

      • 8.8.3 Operating business segments

      • 8.8.4 Product portfolio

      • 8.8.5 Business performance

      • 8.8.6 Key strategic moves and developments

    • 8.9 Johnson and Johnson

      • 8.9.1 Company overview

      • 8.9.2 Company snapshot

      • 8.9.3 Operating business segments

      • 8.9.4 Product portfolio

      • 8.9.5 Business performance

      • 8.9.6 Key strategic moves and developments

    • 8.10 Omron Corporation

      • 8.10.1 Company overview

      • 8.10.2 Company snapshot

      • 8.10.3 Operating business segments

      • 8.10.4 Product portfolio

      • 8.10.5 Business performance

      • 8.10.6 Key strategic moves and developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
    TABLE 2. REMOTE PATIENT MONITORING MARKET REVENUE, FOR CONGESTIVE HEART FAILURE (CHF), BY REGION , 2021-2031,($MILLION)
    TABLE 3. REMOTE PATIENT MONITORING MARKET FOR CONGESTIVE HEART FAILURE (CHF) BY COUNTRY, 2021-2031,($MILLION)
    TABLE 4. REMOTE PATIENT MONITORING MARKET REVENUE, FOR DIABETES, BY REGION , 2021-2031,($MILLION)
    TABLE 5. REMOTE PATIENT MONITORING MARKET FOR DIABETES BY COUNTRY, 2021-2031,($MILLION)
    TABLE 6. REMOTE PATIENT MONITORING MARKET REVENUE, FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BY REGION , 2021-2031,($MILLION)
    TABLE 7. REMOTE PATIENT MONITORING MARKET FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) BY COUNTRY, 2021-2031,($MILLION)
    TABLE 8. REMOTE PATIENT MONITORING MARKET REVENUE, FOR BLOOD PRESSURE, BY REGION , 2021-2031,($MILLION)
    TABLE 9. REMOTE PATIENT MONITORING MARKET FOR BLOOD PRESSURE BY COUNTRY, 2021-2031,($MILLION)
    TABLE 10. REMOTE PATIENT MONITORING MARKET REVENUE, FOR MENTAL HEALTH, BY REGION , 2021-2031,($MILLION)
    TABLE 11. REMOTE PATIENT MONITORING MARKET FOR MENTAL HEALTH BY COUNTRY, 2021-2031,($MILLION)
    TABLE 12. REMOTE PATIENT MONITORING MARKET REVENUE, FOR OTHERS, BY REGION , 2021-2031,($MILLION)
    TABLE 13. REMOTE PATIENT MONITORING MARKET FOR OTHERS BY COUNTRY, 2021-2031,($MILLION)
    TABLE 14. GLOBAL REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
    TABLE 15. REMOTE PATIENT MONITORING MARKET REVENUE, FOR DEVICES, BY REGION , 2021-2031,($MILLION)
    TABLE 16. REMOTE PATIENT MONITORING MARKET FOR DEVICES BY COUNTRY, 2021-2031,($MILLION)
    TABLE 17. REMOTE PATIENT MONITORING MARKET REVENUE, FOR SOFTWARE, BY REGION , 2021-2031,($MILLION)
    TABLE 18. REMOTE PATIENT MONITORING MARKET FOR SOFTWARE BY COUNTRY, 2021-2031,($MILLION)
    TABLE 19. REMOTE PATIENT MONITORING MARKET, BY REGION, 2021-2031,($MILLION)
    TABLE 20. NORTH AMERICA REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
    TABLE 21. NORTH AMERICA REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
    TABLE 22. NORTH AMERICA REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2021-2031,($MILLION)
    TABLE 23. U.S. REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
    TABLE 24. U.S. REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
    TABLE 25. CANADA REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
    TABLE 26. CANADA REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
    TABLE 27. MEXICO REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
    TABLE 28. MEXICO REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
    TABLE 29. EUROPE REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
    TABLE 30. EUROPE REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
    TABLE 31. EUROPE REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2021-2031,($MILLION)
    TABLE 32. GERMANY REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
    TABLE 33. GERMANY REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
    TABLE 34. FRANCE REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
    TABLE 35. FRANCE REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
    TABLE 36. U.K. REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
    TABLE 37. U.K. REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
    TABLE 38. ITALY REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
    TABLE 39. ITALY REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
    TABLE 40. SPAIN REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
    TABLE 41. SPAIN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
    TABLE 42. REST OF EUROPE REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
    TABLE 43. REST OF EUROPE REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
    TABLE 44. ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
    TABLE 45. ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
    TABLE 46. ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2021-2031,($MILLION)
    TABLE 47. JAPAN REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
    TABLE 48. JAPAN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
    TABLE 49. CHINA REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
    TABLE 50. CHINA REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
    TABLE 51. AUSTRALIA REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
    TABLE 52. AUSTRALIA REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
    TABLE 53. INDIA REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
    TABLE 54. INDIA REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
    TABLE 55. SOUTH KOREA REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
    TABLE 56. SOUTH KOREA REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
    TABLE 57. REST OF ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
    TABLE 58. REST OF ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
    TABLE 59. LAMEA REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
    TABLE 60. LAMEA REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
    TABLE 61. LAMEA REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2021-2031,($MILLION)
    TABLE 62. BRAZIL REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
    TABLE 63. BRAZIL REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
    TABLE 64. SAUDI ARABIA REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
    TABLE 65. SAUDI ARABIA REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
    TABLE 66. SOUTH AFRICA REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
    TABLE 67. SOUTH AFRICA REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
    TABLE 68. REST OF LAMEA REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
    TABLE 69. REST OF LAMEA REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
    TABLE 70.AEROTEL MEDICAL SYSTEMS (1988) LTD.: COMPANY SNAPSHOT
    TABLE 71.AEROTEL MEDICAL SYSTEMS (1988) LTD.: OPERATING SEGMENTS
    TABLE 72.AEROTEL MEDICAL SYSTEMS (1988) LTD.: PRODUCT PORTFOLIO
    TABLE 73.AEROTEL MEDICAL SYSTEMS (1988) LTD.: NET SALES,
    TABLE 74.AEROTEL MEDICAL SYSTEMS (1988) LTD.: KEY STRATERGIES
    TABLE 75.BIOTRONIK SE & CO. KG: COMPANY SNAPSHOT
    TABLE 76.BIOTRONIK SE & CO. KG: OPERATING SEGMENTS
    TABLE 77.BIOTRONIK SE & CO. KG: PRODUCT PORTFOLIO
    TABLE 78.BIOTRONIK SE & CO. KG: NET SALES,
    TABLE 79.BIOTRONIK SE & CO. KG: KEY STRATERGIES
    TABLE 80.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
    TABLE 81.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
    TABLE 82.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
    TABLE 83.BOSTON SCIENTIFIC CORPORATION: NET SALES,
    TABLE 84.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
    TABLE 85.GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT
    TABLE 86.GENERAL ELECTRIC COMPANY: OPERATING SEGMENTS
    TABLE 87.GENERAL ELECTRIC COMPANY: PRODUCT PORTFOLIO
    TABLE 88.GENERAL ELECTRIC COMPANY: NET SALES,
    TABLE 89.GENERAL ELECTRIC COMPANY: KEY STRATERGIES
    TABLE 90.NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
    TABLE 91.NIHON KOHDEN CORPORATION: OPERATING SEGMENTS
    TABLE 92.NIHON KOHDEN CORPORATION: PRODUCT PORTFOLIO
    TABLE 93.NIHON KOHDEN CORPORATION: NET SALES,
    TABLE 94.NIHON KOHDEN CORPORATION: KEY STRATERGIES
    TABLE 107.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
    TABLE 108.ABBOTT LABORATORIES: NET SALES,
    TABLE 109.ABBOTT LABORATORIES: KEY STRATERGIES
    TABLE 110.JOHNSON AND JOHNSON: COMPANY SNAPSHOT
    TABLE 111.JOHNSON AND JOHNSON: OPERATING SEGMENTS
    TABLE 112.JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
    TABLE 113.JOHNSON AND JOHNSON: NET SALES,
    TABLE 114.JOHNSON AND JOHNSON: KEY STRATERGIES
    TABLE 115.OMRON CORPORATION: COMPANY SNAPSHOT
    TABLE 116.OMRON CORPORATION: OPERATING SEGMENTS
    TABLE 117.OMRON CORPORATION: PRODUCT PORTFOLIO
    TABLE 118.OMRON CORPORATION: NET SALES,
    TABLE 95.MEDTRONIC PLC: COMPANY SNAPSHOT
    TABLE 96.MEDTRONIC PLC: OPERATING SEGMENTS
    TABLE 97.MEDTRONIC PLC: PRODUCT PORTFOLIO
    TABLE 98.MEDTRONIC PLC: NET SALES,
    TABLE 99.MEDTRONIC PLC: KEY STRATERGIES
    TABLE 100.MASIMO CORPORATION: COMPANY SNAPSHOT
    TABLE 101.MASIMO CORPORATION: OPERATING SEGMENTS
    TABLE 102.MASIMO CORPORATION: PRODUCT PORTFOLIO
    TABLE 103.MASIMO CORPORATION: NET SALES,
    TABLE 104.MASIMO CORPORATION: KEY STRATERGIES
    TABLE 105.ABBOTT LABORATORIES: COMPANY SNAPSHOT
    TABLE 106.ABBOTT LABORATORIES: OPERATING SEGMENTS
    TABLE 119.OMRON CORPORATION: KEY STRATERGIES
  • LIST OF FIGURES

  • FIGURE 1.REMOTE PATIENT MONITORING MARKET SEGMENTATION
    FIGURE 2.REMOTE PATIENT MONITORING MARKET,2021-2031
    FIGURE 3.REMOTE PATIENT MONITORING MARKET,2021-2031
    FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
    FIGURE 5.PORTER FIVE-1
    FIGURE 6.PORTER FIVE-2
    FIGURE 7.PORTER FIVE-3
    FIGURE 8.PORTER FIVE-4
    FIGURE 9.PORTER FIVE-5
    FIGURE 10.TOP PLAYER POSITIONING
    FIGURE 11.REMOTE PATIENT MONITORING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 12.REMOTE PATIENT MONITORING MARKET,BY CONDITION,2021(%)
    FIGURE 13.COMPARATIVE SHARE ANALYSIS OF CONGESTIVE HEART FAILURE (CHF) REMOTE PATIENT MONITORING MARKET,2021-2031(%)
    FIGURE 14.COMPARATIVE SHARE ANALYSIS OF DIABETES REMOTE PATIENT MONITORING MARKET,2021-2031(%)
    FIGURE 15.COMPARATIVE SHARE ANALYSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) REMOTE PATIENT MONITORING MARKET,2021-2031(%)
    FIGURE 16.COMPARATIVE SHARE ANALYSIS OF BLOOD PRESSURE REMOTE PATIENT MONITORING MARKET,2021-2031(%)
    FIGURE 17.COMPARATIVE SHARE ANALYSIS OF MENTAL HEALTH REMOTE PATIENT MONITORING MARKET,2021-2031(%)
    FIGURE 18.COMPARATIVE SHARE ANALYSIS OF OTHERS REMOTE PATIENT MONITORING MARKET,2021-2031(%)
    FIGURE 19.REMOTE PATIENT MONITORING MARKET,BY COMPONENT,2021(%)
    FIGURE 20.COMPARATIVE SHARE ANALYSIS OF DEVICES REMOTE PATIENT MONITORING MARKET,2021-2031(%)
    FIGURE 21.COMPARATIVE SHARE ANALYSIS OF SOFTWARE REMOTE PATIENT MONITORING MARKET,2021-2031(%)
    FIGURE 22.REMOTE PATIENT MONITORING MARKET BY REGION,2021
    FIGURE 23.U.S. REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
    FIGURE 24.CANADA REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
    FIGURE 25.MEXICO REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
    FIGURE 26.GERMANY REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
    FIGURE 27.FRANCE REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
    FIGURE 28.U.K. REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
    FIGURE 29.ITALY REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
    FIGURE 30.SPAIN REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
    FIGURE 31.REST OF EUROPE REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
    FIGURE 32.JAPAN REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
    FIGURE 33.CHINA REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
    FIGURE 34.AUSTRALIA REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
    FIGURE 35.INDIA REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
    FIGURE 36.SOUTH KOREA REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
    FIGURE 37.REST OF ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
    FIGURE 38.BRAZIL REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
    FIGURE 39.SAUDI ARABIA REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
    FIGURE 40.SOUTH AFRICA REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
    FIGURE 41.REST OF LAMEA REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
    FIGURE 42. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 45.PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 46.COMPETITIVE DASHBOARD
    FIGURE 47.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
    FIGURE 48.AEROTEL MEDICAL SYSTEMS (1988) LTD..: NET SALES ,($MILLION)
    FIGURE 49.BIOTRONIK SE & CO. KG.: NET SALES ,($MILLION)
    FIGURE 50.BOSTON SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
    FIGURE 51.GENERAL ELECTRIC COMPANY.: NET SALES ,($MILLION)
    FIGURE 52.NIHON KOHDEN CORPORATION.: NET SALES ,($MILLION)
    FIGURE 53.MEDTRONIC PLC.: NET SALES ,($MILLION)
    FIGURE 54.MASIMO CORPORATION.: NET SALES ,($MILLION)
    FIGURE 55.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
    FIGURE 56.JOHNSON AND JOHNSON.: NET SALES ,($MILLION)
    FIGURE 57.OMRON CORPORATION.: NET SALES ,($MILLION)

Purchase Full Report of
Remote Patient Monitoring Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue